ConforMIS Inc. (NASDAQ:CFMS) saw an uptick in trading volume on Monday . 519,043 shares traded hands during trading, an increase of 62% from the previous session’s volume of 321,031 shares.The stock last traded at $8.93 and had previously closed at $8.18.

Several brokerages have issued reports on CFMS. JPMorgan Chase & Co. dropped their target price on ConforMIS from $11.00 to $8.00 and set a “neutral” rating for the company in a research report on Tuesday, August 9th. Oppenheimer Holdings Inc. boosted their target price on ConforMIS from $12.00 to $13.00 and gave the company an “outperform” rating in a research report on Tuesday, August 9th. Zacks Investment Research upgraded ConforMIS from a “sell” rating to a “hold” rating in a research report on Wednesday, July 13th. Finally, Canaccord Genuity restated a “buy” rating on shares of ConforMIS in a research report on Saturday, May 14th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $15.40.

The firm’s 50 day moving average is $7.32 and its 200-day moving average is $8.96. The company’s market capitalization is $355.97 million.

ConforMIS (NASDAQ:CFMS) last released its quarterly earnings results on Monday, August 8th. The company reported ($0.34) earnings per share for the quarter, topping the consensus estimate of ($0.35) by $0.01. The company had revenue of $19.30 million for the quarter, compared to analyst estimates of $18.02 million. During the same quarter last year, the company earned ($2.51) EPS. The firm’s revenue for the quarter was up .5% on a year-over-year basis. On average, analysts expect that ConforMIS Inc. will post ($1.41) EPS for the current fiscal year.

A hedge fund recently raised its stake in ConforMIS stock. RS Investment Management Co. LLC raised its position in shares of ConforMIS Inc. (NASDAQ:CFMS) by 3.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,432,470 shares of the company’s stock after buying an additional 43,490 shares during the period. RS Investment Management Co. LLC owned approximately 3.52% of ConforMIS worth $24,767,000 at the end of the most recent quarter.

ConforMIS, Inc is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.